NOVONIX Statistics

Total Valuation

NOVONIX has a market cap or net worth of AUD 305.30 million. The enterprise value is 351.99 million.

Market Cap	305.30M
Enterprise Value	351.99M

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	n/a

Share Statistics

NOVONIX has 636.04 million shares outstanding. The number of shares has increased by 1.93% in one year.

Current Share Class	n/a
Shares Outstanding	636.04M
Shares Change (YoY)	+1.93%
Shares Change (QoQ)	+3.26%
Owned by Insiders (%)	5.98%
Owned by Institutions (%)	11.03%
Float	495.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.21
PB Ratio	1.23
P/TBV Ratio	1.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.91
EV / Sales	37.21
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.10

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.52.

Current Ratio	1.24
Quick Ratio	1.10
Debt / Equity	0.52
Debt / EBITDA	n/a
Debt / FCF	-1.02
Interest Coverage	-15.36

Financial Efficiency

Return on equity (ROE) is -46.54% and return on invested capital (ROIC) is -14.71%.

Return on Equity (ROE)	-46.54%
Return on Assets (ROA)	-13.90%
Return on Invested Capital (ROIC)	-14.71%
Return on Capital Employed (ROCE)	-30.25%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	0.78

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.53% in the last 52 weeks. The beta is 1.31, so NOVONIX's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	-43.53%
50-Day Moving Average	0.52
200-Day Moving Average	0.65
Relative Strength Index (RSI)	47.55
Average Volume (20 Days)	5,078,432

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NOVONIX had revenue of AUD 9.46 million and -120.91 million in losses. Loss per share was -0.24.

Revenue	9.46M
Gross Profit	6.60M
Operating Income	-87.92M
Pretax Income	-120.75M
Net Income	-120.91M
EBITDA	-81.54M
EBIT	-87.92M
Loss Per Share	-0.24

Full Income Statement

Balance Sheet

The company has 68.77 million in cash and 115.46 million in debt, giving a net cash position of -46.69 million or -0.07 per share.

Cash & Cash Equivalents	68.77M
Total Debt	115.46M
Net Cash	-46.69M
Net Cash Per Share	-0.07
Equity (Book Value)	222.33M
Book Value Per Share	0.39
Working Capital	17.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -65.31 million and capital expenditures -48.33 million, giving a free cash flow of -113.64 million.

Operating Cash Flow	-65.31M
Capital Expenditures	-48.33M
Free Cash Flow	-113.64M
FCF Per Share	-0.18

Full Cash Flow Statement

Margins

Gross Margin	69.76%
Operating Margin	-929.39%
Pretax Margin	-1,276.38%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NOVONIX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.93%
Shareholder Yield	-1.93%
Earnings Yield	-39.60%
FCF Yield	-37.22%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NOVONIX has an Altman Z-Score of -0.68. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.68
Piotroski F-Score	n/a